| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.01 | 0.9 |